Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M100,585Revenue $M34,858Net Margin (%)44.2Altman Z-Score2.0
Enterprise Value $M118,570EPS $1.7Operating Margin %51.0Piotroski F-Score6
P/E(ttm)6.5Beneish M-Score-2.0Pre-tax Margin (%)52.1Higher ROA y-yY
Price/Book8.810-y EBITDA Growth Rate %0.5Quick Ratio1.0Cash flow > EarningsN
Price/Sales2.95-y EBITDA Growth Rate %-5.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow22.9y-y EBITDA Growth Rate %62.7ROA % (ttm)23.4Higher Current Ratio y-yY
Dividend Yield %6.0PEG--ROE % (ttm)173Less Shares Outstanding y-yY
Payout Ratio %38.0Shares Outstanding M2,415ROIC % (ttm)53.3Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKCharles Brandes 2015-03-31 Add0.38%$41.68 - $48.81
($45.86)
$ 42.26-8%Add 18.20%3,879,073
GSKNWQ Managers 2015-03-31 Add0.14%$41.68 - $48.81
($45.86)
$ 42.26-8%Add 123.03%456,380
GSKKahn Brothers 2015-03-31 Add0.06%$41.68 - $48.81
($45.86)
$ 42.26-8%Add 14.12%58,200
GSKDodge & Cox 2015-03-31 Reduce-0.02%$41.68 - $48.81
($45.86)
$ 42.26-8%Reduce 2.18%23,436,551
GSKHOTCHKIS & WILEY 2015-03-31 Add0.01%$41.68 - $48.81
($45.86)
$ 42.26-8%Add 0.73%12,302,975
GSKJoel Greenblatt 2015-03-31 Add$41.68 - $48.81
($45.86)
$ 42.26-8%Add 0.41%83,578
GSKKen Fisher 2015-03-31 Reduce$41.68 - $48.81
($45.86)
$ 42.26-8%Reduce 0.07%10,757,080
GSKTweedy Browne 2015-03-31 Reduce$41.68 - $48.81
($45.86)
$ 42.26-8%Reduce 2.19%131,346
GSKDodge & Cox 2014-12-31 Reduce-0.64%$41.3 - $47.14
($44.76)
$ 42.26-6%Reduce 37.91%23,959,301
GSKHOTCHKIS & WILEY 2014-12-31 Add0.21%$41.3 - $47.14
($44.76)
$ 42.26-6%Add 13.04%12,213,885
GSKDavid Dreman 2014-12-31 Sold Out -0.01%$41.3 - $47.14
($44.77)
$ 42.26-6%Sold Out0
GSKDodge & Cox 2014-09-30 Reduce-1.11%$46.29 - $54.52
($49.01)
$ 42.26-14%Reduce 35.93%38,589,161
GSKHOTCHKIS & WILEY 2014-09-30 Add0.98%$46.29 - $54.52
($49.01)
$ 42.26-14%Add 118.31%10,804,564
GSKCharles Brandes 2014-09-30 Add0.56%$46.29 - $54.52
($49.01)
$ 42.26-14%Add 36.63%3,415,717
GSKKahn Brothers 2014-09-30 Buy 0.38%$46.29 - $54.52
($49.01)
$ 42.26-14%New holding51,000
GSKNWQ Managers 2014-09-30 Add0.03%$46.29 - $54.52
($49.01)
$ 42.26-14%Add 39.82%208,125
GSKDavid Dreman 2014-09-30 Buy 0.01%$46.29 - $54.52
($49.01)
$ 42.26-14%New holding1,328
GSKHOTCHKIS & WILEY 2014-06-30 Add0.93%$51.55 - $56.39
($54.16)
$ 42.26-22%Add 13358.60%4,949,118
GSKJohn Rogers 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 42.26-22%Add 49.33%988,772
GSKCharles Brandes 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 42.26-22%Add 15.52%2,500,048
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2292.09view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.1499.91view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29698.87view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12252.17view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14201.86view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12252.17view

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    JW1 Jun 29 2015 
    JW1 Jun 28 2015 
    JW1 Jun 28 2015 
    JW1 Jun 28 2015 
    Weekly 3-Year Low Highlights: GSK, TRP, NOV, CHK Jun 15 2015 
    Guru Stocks at 52-Week Lows: XOM, WMT, PG, CVX, GSK Jun 14 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Hotchkis & Wiley Large Cap Value Fund Q1 2015 Commentary May 22 2015 
    Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer May 22 2015 
    9 International Dividend Dogs With Upside Potential May 22 2015 

    More From Other Websites
    GSK tries to repair image in China with HIV drug tie-up Jul 02 2015
    GSK's Viiv arm agrees China tie-up to produce HIV drugs Jul 02 2015
    Manufacturing deal wins China cheap supply of GSK's new HIV drug Jul 02 2015
    ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of... Jul 02 2015
    A Blue-Chip Starter Portfolio: GlaxoSmithKline plc, Royal Dutch Shell Plc And BHP Billiton plc Jul 02 2015
    GlaxoSmithKline to open $95M nonprofit cell research center in Seattle Jul 01 2015
    Scientists find new evidence on GSK vaccine link to narcolepsy Jul 01 2015
    4 Shares To Buy On Market Dips: GlaxoSmithKline plc, SABMiller plc, Dignity Plc & Britvic Plc Jul 01 2015
    Drug companies grilled over Aust pricing Jul 01 2015
    Inquiry asks about drug price 'rip-off' Jun 30 2015
    Big pharma to be grilled on tax avoidance Jun 30 2015
    Pharma giant GlaxoSmithKline reveals $175K paid to hundreds of Triangle doctors Jun 30 2015
    Glaxo Paid Doctors $15 Million Before Pledge to End Fees in 2016 Jun 30 2015
    4 Shares Yielding More Than 5%: GlaxoSmithKline plc, SSE plc, Infinis Energy plc & John Laing... Jun 30 2015
    Dow 30 Stock Roundup: Nike Beats Estimates, Verizon Closes AOL Buy - Analyst Blog Jun 26 2015
    GlaxoSmithKline upgraded by Liberum Jun 26 2015
    Glaxo, Pfizer Meningitis B Vaccines Get ACIP's Category B - Analyst Blog Jun 25 2015
    U.S. CDC committee recommends physicians make individual decisions on the use of meningococcal group... Jun 24 2015
    Why Ashmore Group plc, GlaxoSmithKline plc, Keller Group plc & GKN plc Look Set To Charge Higher! Jun 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK